Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY
Show Display Options
RSS Create an RSS feed from your search for:
AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)
Condition: Avascular Necrosis of Femur Head
Interventions: Procedure: core decompression;   Procedure: Enriched BMCs implantation combined with core decompression
2 Completed Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head
Condition: Avascular Necrosis of Femoral Head
Intervention: Drug: zoledronic acid (aclasta)
3 Recruiting Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
Condition: Avascular Necrosis of Femur Head
Interventions: Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
4 Recruiting Rotational Thromboelastography Study in Tranexamic Acid and Colloid Infusion
Conditions: Avascular Necrosis of Femoral Head;   Degenerative Arthritis of Hip
Intervention: Drug: Tranexamic Acid
5 Completed The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral Head
Condition: Femoral Head Avascular Necrosis
Intervention: Drug: Pamidronate Disodium
6 Completed Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head
Condition: Osteonecrosis
Intervention: Biological: CD133+ cells
7 Recruiting Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip
Condition: Avascular Necrosis of the Femoral Head
Intervention: Biological: Cultured autologous Mesenchymal Cells
8 Terminated A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement
Conditions: Osteoarthritis;   Post-traumatic Arthritis;   Collagen Disorders;   Avascular Necrosis;   Traumatic Femoral Fractures;   Nonunion of Femoral Fractures;   Congenital Hip Dysplasia;   Slipped Capital Femoral Epiphysis;   Perthes Disease
Interventions: Device: Future Hip;   Device: Omniflex;   Device: Zueymüller;   Device: CLS Spotorno
9 Terminated Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Post-traumatic Arthritis;   Collagen Disorders;   Avascular Necrosis;   Nonunion of Femoral Fractures;   Congenital Hip Dysplasia;   Slipped Capital Femoral Epiphysis
Interventions: Device: DePuy ASR™ Hip System;   Device: DePuy ASR™ XL Head / ASR™ Acetabular Cup System
10 Recruiting AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
Conditions: Osteoarthritis;   Arthritis;   Avascular Necrosis;   Fracture of the Femoral Neck or Head;   Congenital Hip Dysplasia
Intervention: Device: AMIStem Hip System
11 Recruiting A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
Conditions: Osteoarthritis;   Arthritis;   Avascular Necrosis;   Fracture of the Femoral Neck or Head;   Congenital Hip Dysplasia
Intervention: Device: Mpact Acetabular Shell

Indicates status has not been verified in more than two years